Trials / Sponsors / Zhejiang DTRM Biopharma
Zhejiang DTRM Biopharma
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma | Phase 2 | 2020-04-24 |
| Completed | BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 1 | 2019-01-11 |
| Completed | Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas Chronic Lymphocytic Leukemia, B-Cell Lymphoma | Phase 1 | 2016-09-01 |
| Completed | Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas Chronic Lymphocytic Leukemia, B-cell Lymphomas | Phase 1 | 2016-09-01 |